Damora Therapeutics, Inc.
NASDAQ:DMRABiotechnology
Healthcare
$22.98 +0.34%
+$0.07 today
- Market cap
- $1.42B
- Beta
- 1.48
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$177.15
52W Low $2.45High $38.33
Volume 0.58M
Average 0.33M
Price history
Damora Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+13.03%
Period high
$34.14
Period low
$16.31
Latest
$22.98
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Aug 13, 2026 | Aug 13, 2026 | |
| 3 | Aug 13, 2026 | Aug 13, 2026 | |
| EFFECT | Aug 12, 2026 | Aug 13, 2026 | |
| POS AM | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| 10-Q | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 POS | Aug 10, 2026 | Aug 10, 2026 |
Competitors
Who does Damora Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about DMRA's filings, answered from its disclosures.
What is the latest DMRA filing?
The latest filing shown is 10-Q dated Nov 4, 2026.
How many recent filings does DMRA have?
Intrinsic Alpha currently shows 20 recent filings for DMRA.
Continue the stock analysis
Jump to another research area for this company.